Scienture Holdings, Inc. Share Price & Technical Analysis
SCNX · $0.40 (0.00%)
Healthcare / Pharmaceutical Retailers
$0.40
0.00%
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of …
Price chart
Seasonality
May has 1 positive and 2 negative years (last 5 years shown)
0% return in May, -3% avg return in past 3 year May month.
-12% return in 2026, -2% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -20% | -25% | 33% | 0% | – | – | – | – | – | – | – | -12% |
| 25 | -38% | -29% | -50% | -36% | 0% | 11% | 90% | -50% | -10% | 0% | -25% | -17% | -153% |
| 24 | -18% | 121% | 5% | -40% | 6% | 72% | -10% | -14% | 1% | 0% | 0% | -20% | 104% |
| 23 | 5% | 0% | -29% | 11% | -14% | 185% | -43% | 3% | -48% | -18% | 0% | -9% | 42% |
| 22 | -15% | -9% | 54% | -36% | -14% | 8% | 4% | -26% | -1% | -23% | -37% | -31% | -125% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$16.08M
P/E ratio
—
52W high
$2.60
52W low
$0.24
Volume
1,38,031
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Scienture Holdings, Inc. share price today?
- Scienture Holdings, Inc. (SCNX) last traded around $0.40 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SCNX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SCNX. Download the app for real-time alerts.
- How can I analyze Scienture Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.